Estrogen and progesterone receptor status and its Association with clinicopathological characteristics Among breast cancer patients: a five-year retrospective Study from january 2021 to december 2025 at jimma University medical center, southwest ethiopia

Abstract

Breast cancer is one of the most common cancers worldwide and a leading cause of cancer related morbidity and mortality. Hormone receptor (HR) status, specifically estrogen receptor (ER) and progesterone receptor (PR), plays a crucial role in guiding treatment decisions and predicting prognosis. However, data on HR expression and its association with clinicopathological characteristics in Ethiopia is limited